Clinical Trial Update: An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 open-label single-arm trial evaluating abatacept for moderate to severe patch-type alopecia areata completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Columbia University | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2019-04-17